Reaferon-EU-Lipint

Реаферон-ЕС-Липинт Drug photo

The description is actual on 06.09.2014

  • Latin name: Reaferon-EU-Lipint
  • ATH code: L03AB04
  • Active ingredient: Interferon alpha 2а (Interferon alfa-2a)
  • Producer: Vektor-Medika closed joint stock company, Russia

Structure

One bottle of drug contains 250000 ME, 500000 ME, 1000000 ME active ingredients.

Excipients:

  • 8,01 mg — sodium chloride;
  • 4,52 mg — sodium dodecahydrate hydrophosphate;
  • 0,56 mg — sodium dihydrate dihydrophosphate;
  • 41,18 mg — lecithin or a lipoid of C100;
  • 0,56 mg — vitamin E;
  • 4,53 mg — cholesterol;
  • 91,34 mg — lactoses.

Release form

Packaging contains 5 or 6 bottles of a different dosage on 1 ml.

Pharmacological action

Antineoplastic, antiviral, immunomodulatory.

Pharmacodynamics and pharmacokinetics

Reaferon-EU-Lipint is intended for internal reception. Oral administration of drug is especially important at therapy of patients of children's age.

From destruction of drug in a human body it is protected by a liposomal cover, it provides passing of interferon through a gastrointestinal tract almost without loss. Getting into a liver drug is soaked up in a circulatory bed where it is slowly released.

At internal reception the content of internal interferon of the person is 100% higher, than at injection introduction of the Reaferona-EU. It is optimum for the emergency therapy and prevention of flu and catarrhal diseases, reducing risk of probability of display of an illness more than twice.

Vitamins E are a part of drug and With which strengthen its antiviral action by 14 times.

Indications to use

Treatment and prevention of flu and ORZ at patients of adult and children's age.

As a part of complex therapy of patients with chronic and acute hepatitises B, including chronic hepatitis B which is complicated by a glomerulonephritis.

Bronchial asthma, atopic pathologies, allergic rinokonjyunktivit at purpose of a specific immunotherapy.

Urogenital chlamydial infection at patients of adult age, as a part of complex treatment.

Contraindications

Side effects

At oral administration in the recommended doses medicine does not cause side effects. However it is worth remembering that active agent of drug — recombinant interferon which at parenteral administration causes grippopodobny symptoms. In this regard patients should observe extra care at purpose of Reaferona-EU-Lipinta with intolerance of the medicines containing interferon.

Application instruction (Way and dosage)

The instruction recommends administration of drug for Reaferon ES Lipint inside (orally).

Before internal reception add the boiled or distilled water of 1-2 ml to contents of a bottle and intensively stir up for 1-5 minutes. At the same time there has to be a full dissolution of powder to formation of homogeneous suspension.

At therapy of an acute hepatitis In adult patients and children of school age accept suspension inside in 30 minutes prior to meal, twice a day in a dose 1000000 ME. A course of treatment — 10 days.

Patients from 3rd to 7 years accept drug in a dose 500000 ME for 10 days once a day.

After carrying out check biochemical analyses of blood continuation of a course of therapy to a total disappearance of clinical symptoms of a disease is possible.

At inactive and active replicative forms of chronic hepatitis B, at the chronic hepatitis B complicated by a glomerulonephritis take Reaferon ES Lipint for the 30th mine before meal.

Recommend to adult patients and patients of school age on 1000000 ME twice a day, for 10 days then pass to one-time reception of the same dose before going to bed, within 30 days.

The dose of drug 500000 ME 2 of time a day for 10 days then pass to one-time reception in the same dose before going to bed, within 30 days is shown to patients from 3rd to 7 years.

At purpose of a specific immunotherapy medicine is accepted once a day, it is preferable in the morning, in 30 minutes after meal.

Therapy of an allergic rinokonjyunktivit at adult patients assumes use of a dose Reaferona ES Lipint 500000 ME for 10 days.

Treatment of atopic bronchial asthma at adult patients takes place in a dose 500000 ME once a day for 10 days then pass to reception of a similar dose every other day for 20 days. General course of therapy 1 month.

For the purpose of prevention of ORZ and flu Reaferon ES Lipint appoint in 30 minutes prior to meal. To patients is more senior than 15 years recommend two times week administration of drug in a dose 500000 ME. The course is intended for 30 day uses during growth of quantity of respiratory diseases.
To patients from 3rd to 15 years appoint the preventive dose 250000 ME accepted within 7 days — 2 times. The course is intended for 30 day uses during growth of quantity of respiratory diseases.

For treatment of ORZ and flu to patients is more senior than 15 years appoint the dose of drug 500000 ME accepted twice a day for 3 days.

Patients from 3rd to 15 years accept a dose of 250000 ME 2 time a day for 3 days.

Complex therapy of urogenital infections demands peroral acceptance of Reaferona-EU-Lipint in the dose 500000 ME broken into two receptions a day for 10 days from adult patients.

Overdose

At observance of the recommended doses, throughout all course of treatment, overdose is impossible.

Interaction

Interferon the alpha has ability to lower activity of R-450 of tsitokhrom, thereby influencing a metabolism of Warfarin, Phenytoinum, Cimetidinum, Curantyl, Diazepam, Theophylline, Propranolol, some tsitostatik.

Reaferon-EU-Lipint can aggravate neurotoxic, cardiotoxic, myelotoxic effect of the medicines which were accepted earlier or in parallel with it.

It is necessary to avoid the combined reception with immunosuppressive drugs and drugs the oppressing TsNS.

Terms of sale

According to the recipe.

Storage conditions

In the refrigerator at a temperature which is not exceeding 8 °C.

Period of validity

12 months.

Analogs

To children

In the recommended doses it is appointed to patients of children's age of 3 years.

Zdravzona

  • Reaferon-EU-Lipint powder for suspension 1 of one million ME No. 5 flakonyvektor-Medika
  • Reaferon-EU-Lipint powder for No. 5 ME suspension 0,5mln flakonyvektor-Medika
  • Reaferon-EU-Lipint powder for No. 5 ME suspension 0,25mln flakonyvektor-Medika
  • Reaferon-EU-Lipint powder for No. 6 ME suspension 0,5mln flakonyvektor-Medika
  • Reaferon-EU-Lipint powder for No. 6 ME suspension 0,25mln flakonyvektor-Medika

Drugstore of IFC

  • Reaferon-EU-Lipint liof. time. 500tys.ed fl 1 ml No. 5, Vektor-Medika Zaorossiya
  • Reaferon-EU-Lipint liof. time. 250tys.ed fl 1 ml No. 5, Vektor-Medika Zaorossiya
to show still
Section: Immunity increase Antiviral
in more detail

Education: Graduated from the Vinnytsia national medical university of N. I. Pirogov, pharmaceutical faculty, the higher pharmaceutical education – the specialty "Pharmacist".

Experience: Work in Koneks and Bios-Media pharmacy chains as "Druggist". Work as "Pharmacist" in Avicenna pharmacy chain of the city of Vinnytsia.

PAY ATTENTION! Information on drugs on the website is help generalizing, collected from public sources and can form the basis for making decision on use of medicines it is not aware of treatment. Before use of medicine of Reaferon-EU-Lipint surely consult with the attending physician.